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Abstract 
Marijuana is the most frequently used illegal substance in the United States and is most 
widely used among young people aged 12 to 21 years. Accurate screening and monitored 
issuance of medical cannabis recommendations have been shown to decrease abuse rates 
of the substance, create fewer deaths from opiates, reduce crime rates, reduce marijuana 
use in youths, decrease car crash deaths, and lessen prevalence of suicide in young men. 
The purpose of this project was to explore whether multiple screening methods for 
depression and anxiety in patients who seek medical cannabis referrals for anxiety and 
depression would improve screening and cannabis referral accuracy. A comprehensive 
review of the literature was conducted, and 2 screening tools were identified. The tools 
identified were the Zung self-rating anxiety scale and the Diagnostic and Statistical 
Manual of Mental Disorders 5 scale. The medical director at the project site reviewed the 
tools and approved them. These tools were then included in an education program for 12 
staff members and providers with a pretest given to the participants prior to the staff 
education program. A posttest was then administered to the same group after the staff 
education program was completed and the new screening measures implemented.  
Results showed that referrals for cannabis were at 85% before the 2-step screening 
process was implemented; referrals for cannabis decreased to 60% with implementation 
of the dual screening method, suggesting increased accuracy in screening for depression 
and anxiety for cannabis referrals. This project might promote positive social change by 
increasing accuracy for cannabis referrals and reducing the risk of cannabis abuse. 
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Section 1: Nature of the Project 
Introduction 
 Marijuana is identified as the most frequently used illegal substance in the United 
States (Buddy, 2018). It is most widely used among young people aged 12 to 21 years 
according to the 2013 National Survey on Drug Use and Health (NSDUH) (Chen, Yu, 
Lasopa, & Cottler, 2017) who have lower perceptions of risk (Wall et al., 2011). 
Dependence syndrome, increased risk for vehicular accidents, impaired respiratory 
function, cardiovascular issues, and effects on adolescent psychosocial development and 
mental health are the most probable adverse effects of regular use of marijuana (Hall & 
Degenhardt, 2009). 
 Cannabis, or medicinal marijuana, is a therapy that has garnered much national 
attention in recent years (Bridgeman & Abaiza, 2017). Controversies surrounding legal, 
ethical, and societal implications associated with use, safe administration, packaging, and 
dispensing; adverse health consequences and deaths attributed to marijuana intoxication; 
and therapeutic indications based on limited clinical data represent some of the 
complexities associated with this treatment (Bridgeman & Abaiza, 2017). Marijuana is 
currently recognized by the U.S. Drug Enforcement Agency’s (DEA’s) Comprehensive 
Drug Abuse Prevention and Control Act (Controlled Substances Act) of 1970 as a 
Schedule I controlled substance and defined as having a high potential for abuse 
(Bridgeman & Abaiza, 2017). 
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The multiple implications for abuse of the substance were due to the availability 
of legal cannabis (Tishler, 2015). A total of 29 states, the District of Columbia, Guam, 
and Puerto Rico now allow for comprehensive public medical marijuana and cannabis 
(Hasin et al., 2015). Legislation passed in California in 2004 allowed nonregistered 
patients to use and possess dried marijuana and plants in quantities reasonably sufficient 
to meet their current medical needs, whereas registered patients are allowed to possess 8 
oz. or not more than six mature or 12 immature plants (Hoffman & Weber, 2010). 
California was one of the first states to legalize medical cannabis use in 1996, allowing 
Californians to possess a physician’s recommendations to acquire and use marijuana for 
medical purposes (Reinarman, Nunberg, Lanthier, & Heddleston, 2011) and not be 
subject to criminal penalties (Hoffman & Weber, 2010). States with medical marijuana 
laws (MMLs) were seen to have higher rates of marijuana use among adolescents than 
those states without MMLs (Wall et al., 2011). 
For this doctoral project, I introduced change in an organization in California that 
screens and issues medical cannabis recommendations to patients who use the substance 
to address their depression and anxiety. Proper screening and monitored issuance of 
medical cannabis recommendation has been shown to decrease abuse rate of the 
substance, cause fewer deaths from opiates, reduce crime rates, reduce marijuana use in 
youths, decrease car crash deaths, and lessen prevalence of suicide in young men 
(Macpherson, 2015). This project is a staff and provider education program that was 
developed to support the new screening methods identified from the literature. 
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In Section 1, I cover the problem statement, the purpose of the project, the nature 
of the project, the significance, and a summary. 
Problem Statement 
Cannabis was proclaimed as particularly beneficial for those with several 
symptoms of psychological disorders such as depression, coping, and social anxiety 
(Bonn-Miller, Boden, Bucossi, & Babson, 2013), and according to Reinarman et al. 
(2011), marijuana is seen by many physicians to have substantial therapeutic uses to 
address symptoms of pain, insomnia, anxiety, panic attacks, sleep disorder, appetite 
issues, seizures, and involuntary movements.  
Legal use of marijuana is a state-level decision and in the United States, 18 states, 
and the District of Columbia, have legalized marijuana to date (National Conference of 
State Legislatures, 2013). In those states, patients are allowed to use and possess small 
quantities of marijuana for medical purposes (Hoffman & Weber, 2010). However, in 
2012, an estimated 74% of adolescents in the United States had used someone else’s 
medical cannabis (Salomonsen-Sautel, Sakai, Thurstone, Corley, & Hopfer, 2012), which 
resulted in adverse effects such as addiction, intoxication, and disturbance in cognitive 
and motor function due to the abuse of the substance (Volkow, Baler, Compton, & Weiss, 
2014). Medical intervention and hospitalization to address the adverse effects will result 
in increase in health care costs (Rapp, 2015).  
Despite the legalization of marijuana in many states, it is categorized as a 
“Schedule 1 controlled substance,” a classification that necessitates nurses to acquire the 
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best understanding of the substance as well as the particular laws in the state where they 
practice (Volkow et al., 2014). An increased need exists for deep understanding 
especially because more and more people in the United States demand for use of medical 
cannabis (Volkow et al., 2014). Awareness of the substance and its effects, policies 
covering the use of cannabis for medical purposes, and actively taking part in the 
screening of patients who need medical cannabis recommendation will enable nurse 
practitioners to perform one of their significant roles which is to save the health care 
industry from spending too much of its funds (Rapp, 2015). 
Physicians in my target organization issue recommendations for medical cannabis 
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming 
through a screening process that patients are qualified. The organization has been using 
one screening method and I have personally witnessed first-time and subsequent-visit 
patients who have been denied of medical cannabis recommendations. As a DNP-
prepared practitioner, I learned from the site that there was a need for identification of 
alternative methods or more than one screening method so patients will not have the 
opportunity to manipulate the screening process on their subsequent visits. Furthermore, 
multiple screening methods are available as researchers have conducted studies on 
various screening tools to ensure that the appropriate screening is used to identify those 
who are eligible for medical cannabis recommendation and to decrease the prevalence of 
the abuse of the said substance (Committee on Substance Abuse, 2011).   
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Purpose 
This doctoral project was guided by the following practice-focused questions: 
 What evidence supports the use of screening methods for patients suffering from 
depression and anxiety and seeking medical cannabis recommendation? 
 What are the results of a staff education on alternative screening methods for 
determination of the need for cannabis referrals in the western United States? 
When managing patients who use medical marijuana, de Vries and Green (2012) 
listed five key points the APN must be aware of: 
 Be well-informed about current research regarding all pharmaceuticals. 
 Educate patients on the physical and psychological effects of medical marijuana, and how 
to interact with legally prescribed medications. 
 Document medical marijuana use as reported by the patient as well as reported effects. 
 Educate the patient on state and federal penalties regarding medical marijuana. 
 Do not supply, fund, obtain, or in any other way prepare medical marijuana for patient 
consumption. 
Therapeutic cannabis use raises a number of dilemmas for nurses (de Vries & 
Green, 2012). They are caught in the middle as marijuana has been declared legal in 
some states while the U.S. DEA declares that the substance has no medical use and has a 
high chance for abuse (Volkow et al., 2014). In addition, although they are aware of the 
adverse effects of marijuana, nurses need to have a deeper understanding of the screening 
for medical cannabis to avoid potential abuse (Volkow et al., 2014). This planned project 
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is also aimed at addressing that gap-in nursing practice by providing a staff education 
program developed to educate nursing staff and providers on the alternative methods for 
screening. 
The introduction of change in the target organization through the use of more than 
one screening method was aimed to ensure appropriate screening, provision of precise 
treatment, reduce adolescent access to diverted medical marijuana, and decrease health 
care costs. My role in this project was to identify alternate screening tools through a 
search of the literature and I provided staff education on the topic and the instruments 
identified. 
Nature of the Doctoral Project 
The target organization is a medical clinic in Orange County, California, which 
caters requests for medical cannabis recommendations. Through formal discussions with 
and approvals from the organization’s leaders, this project identified alternative screening 
processes, provided the foundations for a significant practice change for screening 
patients who request medical cannabis, and used the AGREE II tool that evaluated the 
alternative instruments that are selected for their effectiveness for implementation at the 
site.  
The target population for the staff education was the staff of the medical clinic. 
Data was gathered within the organization and were the actual results of assessments and 
screening procedures done by the clinic’s primary Physician and medical assistant.  
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Significance 
The clinic’s physicians, nurses, medical manager, and administrative staff are the 
main stakeholders of this project. Their active participation in this endeavor was 
significant to achieve the goal of making significant contributions to the health care 
industry and in promoting positive social change. Moreover, appropriate screening should 
ensure that medical cannabis recommendations are only provided to qualified patients to 
avoid further adolescent access to diverted medical marijuana and to decrease substance 
abuse rates (Salomonsen-Sautel et al., 2012), decrease health care costs (Lizeretti & 
Extremera, 2011), and help improve the lives of the target population.  
The success of this doctoral project may prove to be beneficial in mental health 
services where abuse of medications was identified (National Institute of Mental Health, 
2016). 
Summary 
All state regulations consent patients to use and acquire small amounts of 
marijuana for medical use (Hoffman & Weber, 2010). As health care providers, we must 
ensure that abuse does not take place and patients are assisted to optimum health 
(Hoffman & Weber, 2010). As an advanced-practice nurse, I acknowledge that status quo 
is no longer applicable in today’s health care system and have the capability of promoting 
efficient policy development.  
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In the following sections of this doctoral project, I address the appropriate model 
that guided this endeavor. Furthermore, I discuss its relevance to nursing practice and 
provide the significance of my role as a DNP student. 
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Section 2: Background and Context 
Introduction 
Cannabis is the preferred medical term for marijuana or cannabis (Lee, 2012). In 
this study, I use the terms marijuana and cannabis interchangeably. Bonn-Miller et al. 
(2013) posited that cannabis is particularly beneficial for those with several symptoms of 
psychological disorders such as depression, coping, and social anxiety. Marijuana is 
perceived by many physicians to have substantial therapeutic benefits to address (not 
only) symptoms of pain, insomnia, sleep disorders, appetite issues, seizures, and 
involuntary movements but also of anxiety and panic attacks (Reinarman et al., 2011).  
California was one of the first states to legalize medical cannabis use in 1996, 
allowing Californians to possess physician’s recommendations to acquire and use 
marijuana for medical purposes (Reinarman et al., 2011) and not be subject to criminal 
penalties (Hoffman & Weber, 2010). Legislation passed in California in 2004 allowed 
nonregistered patients to use and possess dried marijuana and plants in quantities 
reasonable enough to meet their current medical needs; registered patients are allowed to 
possess 8 oz. or not more than six mature or 12 immature plants (Hoffman & Weber, 
2010). Although the California law placed restrictions on the legal use of the drug, abuses 
still have occurred. Providers who prescribed cannabis did not consistently know if the 
patient continued to need the drug. Therefore, a screening process was implemented. 
Proper screening and monitored issuance of medical cannabis recommendations 
resulted in a decreased abuse rate of the substance, caused fewer deaths from opiates, 
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reduced crime rates, reduced marijuana used in youths, decreased car crash deaths, and 
lessened prevalence of suicide in young men (Macpherson, 2015). However, an estimated 
74% of adolescents in the United States had used someone else’s medical cannabis 
(Salomonsen-Sautel et al., 2012), which resulted in adverse effects such as addiction, 
intoxication, and disturbance in cognitive and motor function due to the abuse of the 
substance (Volkow et al., 2014). Cannabis abuse is costly in terms of medical 
interventions and hospitalizations to address the adverse effects of cannabis abuse 
affecting not only hospital costs, but costs to the families and patients who use it when 
the need no longer exists (Rapp, 2015).  
Physicians in my target organization issue recommendations for medical cannabis 
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming 
through a screening process that patients are qualified. The organization has been using 
one-screening method. With only one-screening method, patients may become familiar 
with the screening tool and know how to answer the questions to assure they will be 
provided a renewal of their cannabis recommendation. For this reason, alternative 
methods of screening are needed. 
As a DNP-prepared practitioner, I recognized the necessity to work on this project 
and presented the relevance of using other screening methods or more than one-screening 
method so patients will not have the opportunity to anticipate the required answers to the 
screening process on their subsequent visits. The Committee on Substance Abuse (2011) 
discussed that studies have been conducted on various screening tools to ensure that the 
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appropriate screening is used to identify those who are eligible for medical cannabis 
recommendation and to decrease the prevalence of the abuse of the substance.  
My aim in this project was to introduce a practice change in the local clinical 
organization through the recommendation of more than one screening method to ensure 
appropriate screening, provision of precise treatment to decrease substance abuse rates 
(Salomonsen-Sautel et al., 2012), decrease health care costs (Lizeretti & Extremera, 
2011), and help improve the lives of the target population and this changed will be 
initiated through staff education. 
The following practice-focused questions guided this doctoral project: 
 What evidence supports the use of screening methods for patients suffering from 
depression and anxiety and seeking medical cannabis recommendation? 
 What are the results of a staff education on alternative screening methods for 
determination of the need for cannabis referrals in the western United States? 
Section 2 covered the concepts, models, & theories, relevance to nursing practice, 
local background and context, and the role of the DNP student. 
Concepts, Models, and Theories 
Nurses are urged to use up-to-date research evidence to deliver the best possible 
care (LoBiondo-Wood, Haber, Berry, & Yost, 2013). Research-based practice has better 
patient outcomes than routine, procedural nursing care and informs nursing decisions, 
actions and interactions with patients (Doody and Doody, 2011). Evidence-based practice 
involves the use of reliable, explicit and judicious evidence to make decisions about the 
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care of individual patients combining the results of well-designed research, clinical 
expertise, patient concerns, and patient preferences (Kueny, Sheyer, Lehan Mackin, & 
Titler, 2015). 
     The Iowa Model of Evidence-Based Practice to Promote Quality Care focuses on 
organization and collaboration incorporating conduct and use of research, along with 
other types of evidence (Titler et al., 2001). This model helped to focus on knowledge- 
and problem-focused triggers, leading to question current nursing practices and whether 
care can be improved through the use of current research findings (Melnyk & Fineout-
Overholt, 2011).  
Using the Iowa Model of Evidence-Based Practice to Promote Quality Care 
involves taking seven essential steps, as follows:     
 Step 1: Selection of a Topic 
Medical cannabis was chosen as the center of this project because of the priority 
and magnitude of the problem, its application to all areas of practice, its contribution to 
improving care, the availability of data and evidence in the problem area, the 
multidisciplinary nature of the problem, and the commitment of staff (Doody & Doody, 
2011). 
Step 2: Forming a Team 
The team is responsible for development, implementation, and evaluation 
(LoBiondo-Wood et al., 2013). The composition of the team should be directed by the 
chosen project and include all interested stakeholders (Doody & Doody, 2011). In 
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creating a team for this project, the team should draw up written policies, procedures and 
guidelines that are evidence-based (LoBiondo-Wood et al., 2013). The medical team may 
perceive task performance as a more justifiable use of time than seeking evidence for 
action or designing guidelines for existing practice (Kueny et al., 2015). For this project, I 
will invite physicians, medical assistants, and nurses from the organization and will 
review the process of the Iowa model steps with them. 
Step 3: Evidence Retrieval 
Evidence was made up of the screening tools gathered from the literature as part 
of my research. The evidence was obtained by using key search terms and the designated 
databases for the search were EBSCO Publishing, CINAHL, Medline, Elsevier, – 
Institute for Healthcare Improvement (ihi.org/), and National Institutes of Health 
(nih.gov/) and I referenced materials from 2014-2018 
Step 4: Grading the Evidence 
In this project, I presented and used at least two screening tools on top of the tool 
that the target organization is currently using and the evidence that supports each one. I 
will grade the evidence using the effectiveness criteria which will relate to whether the 
intervention achieves the intended outcomes (Doody & Doody, 2011). This evidence will 
be presented to the project team. 
Step 5: Developing an Evidence-Based Practice Standard  
Team members conform to agree on recommendations for practice after a critique 
of the literature (Doody & Doody, 2011). Medical marijuana in evidence-based practice 
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is ideally a patient-centered approach, which when implemented, is highly individualized 
(LoBiondo-Wood et al., 2013). In this project, I will set up a time for the team to meet to 
go review the materials I have collected and to discuss the merits of each. As a group, at 
least two alternative strategies for screening will be selected. 
Step 6: Implementing Evidence-Based Practice 
LoBiondo-Wood et al. (2013) discussed that features such as written policies, 
procedures, and guidelines that are evidence-based need to be considered for 
implementations to take place. Social and organizational factors can influence 
implementation and support placed on the integration of evidence into practice is 
essential (Kueny et al., 2015). For this project, I will develop the policy for the use of the 
selected screening tools and will ask the project team to provide feedback on the content 
and the timeline for implementation. 
Step 7: Evaluation 
This is a significant phase that will assess the value and contribution of the 
evidence into practice (Doody & Doody, 2011). Audit and feedback through the process 
of implementation should be conducted (Ivers et al., 2012) and success will not be 
achieved without support from frontline leaders and the organization (Moon & Kim 
2015). For this phase I will develop evaluation tools for use by the site after 
implementation and will provide education classes to the multidisciplinary staff at the 
site. 
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Relevance to Nursing Practice 
Despite the legalization of marijuana in many states, cannabis is categorized as a 
“Schedule 1 controlled substance,” a classification that necessitates nurses to acquire the 
best understanding of the substance as well as the particular laws in the state where they 
practice (Volkow et al., 2014). An increased need exists for deep understanding 
especially because more people in the United States of patients who need medical 
cannabis recommendation will enable nurse practitioners to perform one of their 
significant roles, which is to save the health care industry from spending too much of its 
funds (Rapp, 2015). This is a significant role, but it was not my main focus in this 
project. The priority was on saving lives and to educate nurses on how to avoid abuse by 
screening first for the need for the drug. 
Therapeutic cannabis use raises a number of dilemmas for nurses (de Vries & 
Green, 2012). They are caught in the middle as marijuana has been declared legal in 
some states, while the U.S. DEA declares that the substance has no medical use and has a 
high chance for abuse (Volkow et al., 2014). Furthermore, although they are aware of the 
adverse effects of marijuana, nurses need to have a deeper understanding of the screening 
for medical cannabis to avoid potential abuse (Volkow et al., 2014). This planned project 
was also aimed at addressing that gap-in nursing practice. 
Local Background and Context 
The target organization is a clinic that performs screening methods to identify 
patients who need medical cannabis to address their anxiety and depression issues. 
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During the completion of my practicum hours in the said clinic, although not directly 
interacting with the patients, I was allowed to collaborate with the medical assistant and 
observe the screening process. I have seen patients who were denied of medical cannabis 
recommendation. Those denied of the recommendation were those who came in “high” 
and smelled of marijuana and manifested loud and aggressive behavior. After undergoing 
the screening process, both the physician and the medical assistant agreed that they need 
cannabis only for recreation purposes. 
The clinic is located in the state of California where medical cannabis use was 
legalized in 1996 allowing Californians to possess physician's recommendations to 
acquire and use marijuana for medical purposes (Reinarman et al., 2011) and not be 
charged with criminal penalties (Hoffman & Weber, 2010). 
Role of the DNP Student  
In compliance to the practicum requirement of this DNP program, I had the 
opportunity to render practicum services in a clinic that screens patients for medical 
cannabis recommendation. My critical thinking as a medical professional was stimulated 
after close observation of the screening process and seeing the possibility of the process 
being manipulated. As a medical practitioner in a state where the use of cannabis has 
been declared legal, I believed in the urgency to make a noteworthy contribution that will 
cause the decrease of the abuse of the substance.  
This project, therefore, becomes not only a compliance to the DNP program 
requirement, but my contribution to the betterment of the lives of the locals or the people 
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at the target community. My roles were mostly related, but not limited to, the gathering of 
evidence, formation of a project team, staff education, completion of this project, and the 
dissemination of information. 
Role of the Project Team  
For this project, I worked closely with a project team, which was made up of the 
head physician, medical assistant, and nurses at the medical clinic that screens patients 
for medical cannabis recommendation. After presenting the potential screening tools, 
evidence was graded and then presented to the team. The project team was granted 
appropriate time to review the materials and decided on at least two alternative strategies 
and provided feedback on the content and the timeline for the implementation.  
Summary 
The Iowa Model of Evidence-Based Practice to Promote Quality Care discussed 
in this section provided the efficient guide to the identification and grading of the 
evidence which was presented to the team. The identification of the relevance of the 
project to nursing practice is another key point of this section. It should provide an 
efficient transition to the succeeding section where the evidence generated will be 
analyzed and synthesized and enable the provision of the connection of the gap in 
practice. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
Cannabis was proclaimed as particularly beneficial for those with several 
symptoms of psychological disorders such as depression, coping, and social anxiety 
(Bonn-Miller et al., 2013), and according to Reinarman et al. (2011), marijuana is seen by 
many physicians to have substantial therapeutic uses to address symptoms of pain, 
insomnia, anxiety, panic attacks, sleep disorder, appetite issues, seizures, and involuntary 
movements.  
Legal use of marijuana is a state-level decision and in the United States, 18 states 
and the District of Columbia have legalized marijuana (National Conference of State 
Legislatures, 2013). In those states, patients are allowed to use and possess small 
quantities of marijuana for medical purposes (Hoffman & Weber, 2010). However, an 
estimated 74% of adolescents in the U.S. had used someone else's medical cannabis 
(Salomonsen-Sautel et al., 2012) which resulted in adverse effects such as addiction, 
intoxication, and disturbance in cognitive and motor function due to the abuse of the 
substance (Volkow et al., 2014). Medical intervention and hospitalization to address the 
adverse effects will result in increase in health care costs (Rapp, 2015).  
Despite the legalization of marijuana in many states, it is still categorized as a 
“Schedule 1 controlled substance”, a classification that necessitates nurses to acquire the 
best understanding of the substance as well as the particular laws in the state where they 
practice (Volkow et al., 2014). There is an increased need for deep understanding 
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especially because more and more people in the U.S. demand for use of medical cannabis 
(Volkow et al., 2014). Awareness of the substance and its effects, policies covering the 
use of cannabis for medical purposes, and actively taking part in the screening of patients 
who need medical cannabis recommendation will enable nurse practitioners to perform 
one of their significant roles which is to save the health care industry from spending too 
much of its funds (Rapp, 2015). 
Physicians in my target organization issue recommendations for medical cannabis 
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming 
through a screening process that patients are qualified. The organization has been using 
one screening method and I have personally witnessed first-time and subsequent-visit 
patients who have been denied of medical cannabis recommendations. As a DNP-
prepared practitioner, I found the necessity to exercise my critical thinking and worked 
on this project and presented the relevance of using more than one screening methods so 
patients will not have the opportunity to manipulate the screening process on their 
subsequent visits. Multiple screening methods have been developed and tested and are 
available for use in primary care setting (Committee on Substance Abuse, 2011).  
Research conducted on various screening tools helps to validate screening tools as a 
mean to identify patients whose condition makes them eligible for medical cannabis 
recommendation and to decrease the prevalence of cannabis abuse (Committee on 
Substance Abuse, 2011).  
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The target organization where this project took place is a clinic that performs 
screening methods to identify patients who need medical cannabis to address their 
anxiety and depression issues. On admission to the organization, patients were screened 
initially then on subsequent visits went swiftly through the screening phase when the 
medical assistant employed the same screening tool used in their initial visit, the online 
screening tool of the Anxiety and Depression Association (ADAA) for Generalized 
Anxiety Disorder (GAD), which the ADAA developed from the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (ADAA, 2018) is used 
at the location. In discussing the screening process with the medical assistant my theory 
was confirmed in patients on subsequent visits quickly completed the form indicating 
they were familiar with the screening method proposed the use of the Zung self-rating 
anxiety scale (Zung SAS) as an alternate screening method. The Zung SAS is a 20-item 
self-assessment designed to quantify a patient’s level of anxiety (Dunstan, Scott, & Todd, 
2017). As a part of their mission and goals, the medical team at the organization aims to 
improve the lives of the locals by making significant contribution in the decreased rate of 
substance abuse by ensuring that medical cannabis recommendations are granted only to 
those who need it for medical purposes by implementing other screening tools. The staff 
did not have the knowledge or skills for alternate screening methods and therefore my 
project focused on searching the literature to identify alternate screening tools, then 
educating the staff on their use. My role in this project was to identify alternate screening 
tools for use at the site. 
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In Section 3, I cover the practice-focused questions, sources of evidence, 
published outcomes and research, archival and operational data, evidence generated for 
the doctoral project, and the analysis and synthesis of information. 
Practice-Focused Questions 
This doctoral project was guided by the following practice-focused questions: 
 What evidence supports the use of screening methods for patients suffering from 
depression and anxiety and seeking medical cannabis recommendation? 
 What are the results of a staff education on alternative screening methods for 
determination of the need for cannabis referrals in the western United States?  
Therapeutic cannabis use raises a number of dilemmas for nurses (de Vries & 
Green, 2012). They are caught in the middle as marijuana has been declared legal in 
some states while the U.S. DEA declares that the substance has no medical use and has a 
high chance for abuse (Volkow et al., 2014). Although nurses are aware of the adverse 
effects of marijuana, nurses need to have a deeper understanding of the screening for 
medical cannabis to avoid potential abuse (Volkow et al., 2014). This lack of knowledge 
of medical cannabis represents the gap in practice that I addressed in this project.  
The introduction of staff education on alternative screening tools to prepare the 
organization for a change in the use of more than one screening method was aimed to 
ensure appropriate screening, provision of precise treatment, reduce adolescent access to 
diverted medical marijuana, and decrease health care costs. 
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Sources of Evidence 
When managing patients who use medical marijuana, de Vries and Green (2012) 
listed five key points for the APN: 
 Be well-informed about current research regarding all pharmaceuticals. 
 Educate patients on the physical and psychological effects of medical marijuana, and how 
to interact with legally prescribed medications. 
 Document medical marijuana use as reported by the patient as well as reported effects. 
 Educate the patient on state and federal penalties regarding medical marijuana. 
 Do not supply, fund, obtain, or in any other way prepare medical marijuana for patient 
consumption. 
Evidence were gathered from the target organization on the current processes for 
screening. I completed a literature search, identified alternate screening methods, and 
then a staff education program was developed and presented to the staff at the site. The 
education program included the evidence obtained from the literature search to support 
the screening tools, educational procedure for use with patients, and steps for how and 
when to alternate the use of the tools. Results were measured through pretests and 
posttests that helped determine the outcome of alternative screening methods for 
determination of the need for cannabis referrals in the western United States. 
Published Outcomes and Research 
Databases and Search Engines 
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The literature review was conducted using databases from CINAHL, Medline, 
and other sources including Elsevier, Institute for Healthcare Improvement (ihi.org/), and 
National Institutes of Health (nih.gov/). 
Search Terms 
Listed are the terms used to search for references to address the concerns raised in 
my practice-focused questions: medical cannabis, screening for medical cannabis 
patient, patients seeking medical cannabis recommendation, medicinal marijuana, 
marijuana, cannabis, and medicinal marijuana study. Inclusion criteria were articles 
published between 2013 and 2018, peer reviewed, and published in the English language. 
Inclusion in the education were nurses and providers who work in the clinic in a large 
western state. 
Marijuana is identified as the most frequently used illegal substance in the United 
States (Buddy, 2018). Cannabis was proclaimed as particularly beneficial for those with 
several symptoms of psychological disorders such as depression, coping, and social 
anxiety (Bonn-Miller et al., 2013). Therapeutic cannabis use raises a number of dilemmas 
for nurses, the cannabis used is usually obtained illegally, which can have consequences 
for both those who use it and nurses who provide treatment in the community. (de Vries 
& Green, 2012).  
Appropriate screening should ensure that medical cannabis recommendations are 
only provided to qualified patients to avoid further adolescent access to diverted medical 
marijuana and to decrease substance abuse rates (Salomonsen-Sautel et al., 2012). 
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Although medical marijuana is used to address some indications such as depression and 
anxiety, the medical staff should be efficiently educated on the proper screening for 
medical cannabis recommendation to ensure that it is appropriately used and the 
recipients of the recommendations will benefit from its use (Hill, 2015) and to reduce the 
frequent and heavy recreational use to evade the increasing levels of cannabis abuse (Hall 
& Degenhardt, 2009). 
Archival and Operational Data 
Nurses are urged to use up-to-date research evidence to deliver the best possible 
care (LoBiondo-Wood et al., 2013). Research-based practice has better patient outcomes 
than routine, procedural nursing care and informs nursing decisions, actions and 
interactions with patients (Doody and Doody, 2011). Evidence-based practice involves 
the use of reliable, explicit and judicious evidence to make decisions about the care of 
individual patients combining the results of well-designed research, clinical expertise, 
patient concerns and patient preferences (Kueny et al., 2015). 
The providers at the site make their referrals after each screening process; 
although use of new instruments will be welcomed by the staff, the need for education on 
how to use the new tools and when and how to rotate their use was the rationale for this 
education project. 
Evidence Generated for the Doctoral Project 
The Iowa model of Evidence-Based Practice to Promote Quality Care focuses on 
organization and collaboration incorporating conduct and use of research, along with 
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other types of evidence (Melnyk & Fineout-Overholt, 2011). This model helped me to 
focus on knowledge- and problem-focused triggers, leading to question current nursing 
practices and whether care can be improved through the use of current research findings 
(Melnyk & Fineout-Overholt, 2011). 
Participants 
The participants for this project were the staff and the providers. I developed and 
provided the education for them using the screening tools that I identified from the 
literature. I provided them with an anonymous consent to participate in the education 
project. I asked them to complete a pretest, sit through an hour-long education program, 
and complete a post-test on the content that I provided. 
Procedure 
Employing the Iowa Model of Evidence-Based Practice to Promote Quality Care 
involves taking seven (7) essential steps, as follows:     
Step 1: Selection of a Topic 
Medical cannabis was chosen as the center of this project because of the priority 
and magnitude of the problem, its application to all areas of practice, its contribution to 
improving care, the availability of data and evidence in the problem area, the 
multidisciplinary nature of the problem, and the commitment of staff (Doody & Doody, 
2011). 
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Step 2: Forming a Team 
The team, which is composed of the staff and the providers, will review the 
evidence and tools that I will identify, the education program and policy that I will 
develop. I will come up with a form that they can fill out so I can get feedback from each 
of the expert panel or team and use that information to improve my education program 
for the staff. 
Step 3: Evidence Retrieval 
The education program was based on the evidence from the screening tools 
gathered from the literature. 
Step 4: Grading the Evidence 
In this project, I presented and employed at least two screening tools on top of the 
tool that the target organization is currently using and the evidence that supports each 
one. I will grade the evidence using the effectiveness criteria which will relate to whether 
the intervention achieves the intended outcomes (Doody & Doody, 2011). This evidence 
will be presented to the project team. 
Step 5: Developing an Evidence-Based Practice Standard  
Team members conform to agree on recommendations for practice after a critique 
of the literature (Doody & Doody, 2011). Medical marijuana in evidence-based practice 
is ideally a patient-centered approach, which when implemented, is highly individualized 
(LoBiondo-Wood et al., 2013). In this project, I will set up a time for the team to meet to 
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go review the materials I have collected and to discuss the merits of each. As a group, at 
least 2 alternative strategies for screening will be selected. 
Step 6: Implementing Evidence-Based Practice 
LoBiondo-Wood et al. (2013) discussed that features such as written policies, 
procedures, and guidelines that are evidence-based need to be considered in order for 
implementations to take place. Social and organizational factors can influence 
implementation and support placed on the integration of evidence into practice is 
essential (Kueny et al., 2015). For this project I developed the policy for the selected 
screening tools and asked the project team to provide feedback on the content and the 
timeline for implementation. 
Step 7: Evaluation 
This is a significant phase that assessed the value and contribution of the evidence 
(Doody & Doody, 2011). Audit and feedback through the process of implementation will 
be conducted by the site after this project is completed (Ivers et al., 2012) and success 
will not be achieved without support from frontline leaders and the organization (Moon 
& Kim 2015). I evaluated the results of the education presentation with a posttest on the 
content presented in the education program. The site will be responsible for completing 
the final evaluation of the implementation as that will take place after this developmental 
stage is completed. 
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Protection 
Cannabis, or medicinal marijuana, is a therapy that has garnered much national 
attention in recent years. (Bridgeman & Abaiza, 2017). Controversies surrounding legal, 
ethical, and societal implications associated with use, safe administration, packaging, and 
dispensing; adverse health consequences and deaths attributed to marijuana intoxication; 
and therapeutic indications based on limited clinical data represent some of the 
complexities associated with this treatment. (Bridgeman & Abaiza, 2017). Marijuana is 
currently recognized by the U.S. DEA’s Comprehensive Drug Abuse Prevention and 
Control Act (Controlled Substances Act) of 1970 as a Schedule I controlled substance 
and defined as having a high potential for abuse (Bridgeman & Abaiza, 2017). 
Institutional Review Board approval was obtained and no data collections or analysis 
occurred until approval has been received. The IRB approval number for the project was 
03-26-19-0725261. Further, to assure protections of the participants of the education 
program, no personal identification was obtained from the participants and the pretest and 
posttest questionnaires had unique identifiers.  
Analyzing and Synthesis 
I have always been in close contact with the clinic manager even when I was not 
permitted to directly interact with the patients. Efficient collaboration with the clinic 
manager provided access and permission to gather, track, record, and organize the 
evidence and to present the education program. The participants were the staff and the 
providers at the clinic. A pretest was administered to them before the education program. 
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Each participant had two copies of the test that had the same unique ID for the pre- and 
post-test. After completion of the pretest, the test was placed in an envelope. I obtained 
the envelope before administering the education program. After the education program 
was completed, I asked the participants to complete the post-test. The post-tests were 
placed in the envelope with the pretests and I collected them without knowing which test 
was provided by any participant.   
Pretest and posttest scores were then entered into an Excel spreadsheet and 
compared against each other. The number of the participants and their individual roles in 
the clinic were reviewed. Results of the pretest and posttest contents were compared. 
Summary 
Evidence to support the education program and the screening tools that were used 
were the result of the literature review.  Data from the pretests and posttests were 
provided by the staff before and after the education program was given. This section 
provides the detail for the plan for the project.   
The succeeding section is aimed to educate the readers of the gap-in-practice and 
the purpose of this doctoral project; sources of evidence and how they were obtained are 
discussed; findings and implications to positive social change are provided; and proposed 
solutions that will address the gap-in-practice are described. 
In Section 4, I work with findings, implications, recommendations, contribution 
of the project team, and the strengths and limitations of the project. 
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Section 4: Findings and Recommendations 
Introduction 
Cannabis was proclaimed as particularly beneficial for those with several 
symptoms of psychological disorders such as depression, coping, and social anxiety 
(Bonn-Miller et al., 2013), and according to Reinarman et al. (2011), marijuana is seen by 
many physicians to have substantial therapeutic uses to address symptoms of pain, 
insomnia, anxiety, panic attacks, sleep disorder, appetite issues, seizures, and involuntary 
movements.  
Despite the legalization of marijuana in many states, it is still categorized as a 
“Schedule 1 controlled substance,” a classification that necessitates nurses to acquire the 
best understanding of the substance as well as the particular laws in the state where they 
practice (Volkow et al., 2014). An increased need exists for deep understanding 
especially because more and more people in the U.S. demand for use of medical cannabis 
(Volkow et al., 2014). Awareness of the substance and its effects, policies covering the 
use of cannabis for medical purposes, and actively taking part in the screening of patients 
who need medical cannabis recommendation will enable nurse practitioners to perform 
one of their significant roles which is to save the health care industry from spending too 
much of its funds (Rapp, 2015). 
Physicians in my target organization issue recommendations for medical cannabis 
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming 
through a screening process that patients are qualified. The organization has been using 
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one screening method and I have personally witnessed first-time and subsequent-visit 
patients who have been denied of medical cannabis recommendations. As a DNP-
prepared practitioner, I saw the necessity to exercise my critical thinking, worked on this 
project and presented the relevance of using other screening methods or more than one 
screening method so patients will not have the opportunity to manipulate the screening 
process on their subsequent visits. More important, the providers at the organization did 
express that they saw the need for alternate methods as they do have patients who come 
for second visits or refills. 
This planned project was also aimed at addressing that gap-in nursing practice by 
providing a staff education program developed to educate nursing staff and providers on 
the alternative methods for screening. The introduction of change in the target 
organization through the use of more than one screening method via staff education 
program was aimed to ensure appropriate screening, provision of precise treatment, 
reduce adolescent access to diverted medical marijuana, and decrease health care costs. 
My role in this project was to identify alternate screening tools through a search of the 
literature and provide staff education on the topic and the instruments identified. 
Evidence were provided by the target organization on their current processes for 
screening. Literature search and study were done to identify alternate screening methods. 
Pre- and Post-tests were administered to the staff at the organization to identify the 
significance of using more than one screening methods on patients seeking medical 
cannabis recommendation.  
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This doctoral project was guided by the following practice-focused questions: 
The project focused-question Number 1 was: What evidence supports the use of 
screening methods for patients suffering from depression and anxiety and seeking 
medical cannabis recommendation? 
Screening tools must be used on patients seeking medical cannabis 
recommendation (Caulkins, Kilmer, & Kleiman, 2016). Health care providers must be 
sure of the need of the patients and these screening tools will help them identify the need 
(Caulkins, Kilmer, & Kleiman, 2016). Caulkins, Kilmer, and Kleiman (2016) further 
discussed that screening methods serve as guide for health care providers in identifying 
which ones can and do manipulate systems; thus, ensure that only those who are truly 
qualified of the recommendations may acquire them. 
To answer project-focused question Number 1, I conducted a literature search to 
identify the most current evidence available on screening tools for cannabis referrals. 
Thorough literature search was done on Walden library, CINAHL, Medline, Elsevier, 
Institute for Healthcare Improvement, and the National Institutes of Health which are 
reliable sources. These sites provided information that indicated authorized groups or 
individuals who stand behind the information they present. The dates of research are also 
given which guide readers to identify that the information presented are recent enough to 
meet the requirement of the paper or project. 
In one of the meetings with the decision-makers of the organization, I was given 
the opportunity to present the two alternate screening methods: 
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 Zung Self-Rating Anxiety Scale (Zung SAS) (See Appendix A). 
 Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) (wee 
Appendix B) with Instructions to Clinicians (See Appendix C). 
The Zung Self-Rating Anxiety Scale (Zung SAS) was designed by W. K. Zung, MD, to 
quantify a patient's level of anxiety. It is a 20-item self-assessment scored on a Likert-
type scale of 1-4 ("a little of the time," "some of the time," "a good part of the time," and 
"most of the time") (Biggs, Wylie, and Ziegler, 1978). ZUNG (SAS) is free and available 
online and was built to assess levels of anxiety based on cognitive, autonomic, motor, and 
central nervous systems manifestations. The final assessment is derived from the total 
score which ranges from 20 to 80. The raw score has an Anxiety Index which is used to 
identify a patient's level of anxiety: 20 to 44, normal range; 45 to 59, mild to moderate 
anxiety level; 60 to 74, marked to severe anxiety level; and 75 to 80, extreme anxiety 
level (Biggs, Wylie, & Ziegler, 1978). 
DSM-5, which stands for the Diagnostic and Statistical Manual of Mental 
Disorders 5, is the result of more than a decade’s effort by mental health experts. The 
latest versions are available online and may be accessed for free. This test stipulates the 
definition and classification of mental disorders to provide advancement in diagnoses, 
treatment, and research. DSM has screening tests for specific disorders and ages, with 
instructions for physicians, scoring, and interpretation (American Psychiatric 
Association, 2013). 
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The project-focused question Number 2 was: What are the results of a staff 
education on alternative screening methods for determination of the need for cannabis 
referrals in the western United States? 
To answer project question Number 2, I prepared the pretest (See Appendix D) 
and posttest (See Appendix E) as well as the staff education program which was created 
after the completion of the literature review and after the screening tools that were 
qualified for use were decided upon. 
The staff benefited from the staff education program as they are made aware and 
reminded of other screening tools which were results of thorough research. Gaining 
knowledge on alternate screening methods helped the staff and the organization identify 
and understand varying behaviors of patients seeking medical cannabis. The ability to 
identify and assess said behaviors will make it possible to avoid manipulation of the 
system; therefore, medical cannabis recommendations will be given only to those who 
truly need them. 
Findings and Implications 
Procedures 
 The participants were given a pre-test before the suggested additional screening 
tools were taught in the education program. The education program on the screening tool 
was discussed during the staff education held within the organization’s premises. The 
pre-tests results were kept in individual envelopes assigned to each participant using a 
unique identifier and no personal information were collected.  
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There were patients on subsequent visits and went swiftly through the screening 
phase when the medical assistant employed the same screening tool they have been using 
which is the online screening tool of the Anxiety and Depression Association (ADAA) 
for Generalized Anxiety Disorder (GAD) which ADAA developed from the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (ADAA, 2018). 
The medical assistant supported my theory from observation that patients on succeeding 
visits may manipulate the existing screening method which they have become familiar 
with; thus he discussed my suggestion of using another screening tool which is the Zung 
Self-Rating Anxiety Scale (Zung SAS), a 20-item self-assessment designed to quantify a 
patient’s level of anxiety. 
After the head physician’s approval and after implementing both the ADAA for 
GAD and the Zung SAS screening tools, some patients were indeed found to not needing 
the drug anymore. As a part of their mission and goals, the medical team at the 
organization aims to improve the lives of the locals by making significant contribution in 
the decreased rate of substance abuse by ensuring that medical cannabis 
recommendations are granted only to those who need it for medical purposes by 
implementing other screening tools. 
 The staff education program was then given to the participants and afterwards the 
post-test questions were administered. Post-tests were given to the participants after the 
education was completed. Post-tests were secured in the same individual envelopes with 
unique IDs and then all were gathered for analysis. 
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Results 
Demographics of participants. The 12 participants are medical practitioners with at least 
a bachelor’s degree. Made up of 4 males and 8 females, the team had been working 
together for at least three years in screening patients for medical cannabis 
recommendation (Table 1).  
Table 1   
 
Demographics 
 
     Gender                                               Male                                      Female 
                                                                (33%)                                        (67%)      
Number of years with                           5 years                         3.8 years average 
the organization                                      (58%)                                           (42%)                                                                                                     
Number of years involvement              5 years                         3.8 years average 
in screening process                               (58%)                                          (42%)                                                                                                     
 
Table 2  
 
Pretest Results 
 
How many screening tools implemented 100% replied : 1 
Have screened patients on subsequent visits 100% replied : YES 
Do you submit reports with recommendations after 
each screening? 
100% replied : YES 
Part of the team that makes final decision on the 
releasing of medical cannabis recommendations 
75% - YES 25% - NO 
Percentage of patients being issued with medical 
cannabis after using one screening tool 
Average 85% 
Based on 85% average of patients being given 
medical cannabis recommendations, would you 
recommend using another screening tool? 
100% replied: YES 
Based on reports with recommendations (by the 
other members of the screening team), what is the 
% of recommendations for medical cannabis? 
Average 85% 
67% said patients are swift in 
answering the screening test; 
33% said patients are impatient, 
anxious to be done immediately 
with the screening process 
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Pretest Results 
Results showed that the participants were familiar with implementing one 
screening tool during the screening process but were not aware of the need for more than 
one screening tool to test for the need for a cannabis referral. All participants indicated 
that the one screening tool was sufficient when answering the questions on the pretest 
indicating a lack of knowledge about options for more than one screening tool or of the 
rationale for the use of more than one screening tool.  
Table 3  
 
Posttest Results 
 
Beneficiary of staff education program 100% replied: YES 
How many screening tools used for this week? 100% replied: 2 
Have screened patients on subsequent visits 75% - YES 25% - NO 
Do you submit reports with recommendations after 
each screening? 
100% replied: YES 
Part of the team that makes final decision on the 
releasing of medical cannabis recommendations 
75% - YES 25% - NO 
Percentage of patients being issued with medical 
cannabis after using one screening tool 
Average 60% 
Based on 60% average of patients being given 
medical cannabis recommendations, would you 
recommend using another screening tool? 
100% replied: YES 
Based on reports with recommendations (by the 
other members of the screening team), what is the 
% of recommendations for medical cannabis? 
Average 60% 
80% said patients seemed restless due to 
unfamiliarity of the tools  
20% said patients are anxious to be done 
immediately with the screening process 
 
Posttest Results   
After the scheduled staff education (See Appendix F), the staff of the organization 
underwent education on the additional screening tools and then post-tests were given to 
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them. Post-tests were secured in individual envelopes and then were gathered for 
analysis. Post-tests showed how the participants gained knowledge from staff education 
and how they are able to differentiate screening process results using one screening tool 
from results using at least two screening tools. All of the participants who were part of 
the team that makes the final decision on the releasing of medical cannabis 
recommendation expressed that they noticed differences in decisions and 
recommendations when two screening tools were used. 
Recommendations 
After the post-test, the manager, along with the clinic’s primary physician, called 
for a team meeting to discuss the result. I presented to them the fact that the post-test 
showed that all of the members of the team that make the final decision on the releasing 
of medical cannabis recommendation expressed that they noticed differences in decisions 
and recommendations when two screening tools were used in the process. Prior to using 
two screening tools, the team approved 85% of requests for medical cannabis 
recommendations (see Table 1). However, after using two alternate screening tools, the 
team saw the need to approve 60% of requests for medical cannabis recommendations. 
The team agreed that it is best to use two screening tools during the screening process. 
The recommendation for screening included continued use of the current tool (Anxiety 
and Depression Association (ADAA) for Generalized Anxiety Disorder (GAD)) and pair 
it with either of the two suggested tools which are Zung-SAS and DSM-5. The team 
agreed to use pairs alternately. Thus, Zung-SAS and DSM-5 for patients on subsequent 
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visits, and ADAA for GAD and pair it with either Zung-SAS or DSM-5 for first-time 
patients. 
Contribution of the Doctoral Project Team 
 The project team was made up of the Manager, Head Physician, Medical 
Assistants, and Nurses at the medical clinic that screens patients for medical cannabis 
recommendation. After presenting the potential screening tools, evidence was graded and 
then presented to the team. The project team was granted appropriate time to review the 
materials and decide on at least two alternative strategies and provided feedback on the 
content and the timeline for the implementation. 
Strengths and Limitations of the Project 
The most important aspect of this project is the fact that the decision makers of 
the organization understood the benefits and agreed to the use of the alternate screening 
tools presented. Also, with the head of the organization being an efficient and respected 
leader and being open to change, the staff education program went along very smoothly. 
The rest of the team were submissive to the activities and were cooperative in both the 
pre- and post-tests. 
Although the project focuses on a small organization which results in a small 
sample size, I don’t see this as a project limitation. At this point, the size may not be an 
issue. What is significant is the result or the response of the team involved. 
While I believe that I have done thorough literature reading and study on the 
subject, I noticed lack of previous research studies on the topic of the significance of 
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using pre-screening tools when performing assessment on patients seeking medical 
cannabis recommendations. 
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Section 5: Dissemination Plan 
Dissemination Plan 
At this point in my project, I am confident that I have clearly described the 
problem in practice in my target organization and that there was a possibility of giving 
medical cannabis recommendations to patients who did not need it. Also, they have been 
using only one screening tool, which made it easier for patients on subsequent visits to go 
through the screening process and acquire medical cannabis recommendations. 
The organization where I aimed to do the staff education program was 
considerably small in size. Therefore, gathering of the significant participants and 
dissemination was not difficult to achieve. The manager made arrangements so that I was 
able to do my PowerPoint presentation in the clinic’s conference room with the entire 
staff/human power on the day that they are closed for business. 
The manager also pointed out the significance of the availability of the primary 
physicians and other members of the team that makes the final decision in who receives 
the medical cannabis recommendation. The staff education program on the alternate 
screening tools would be beneficial not only in outpatient clinics such as the target 
organization, but also in other inpatient health care facilities. 
The dissemination plan included the discussion of the alternate screening tools 
and the results of the pre- and post-tests where majority of the participants and/or project 
team members agreed that it is best to use two more alternate screening tools on top of 
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the one which is currently being used. The manager requested electronic copies of the 
dissemination saved in various files and computers in their organization. 
Analysis of Self 
 Seeing the reality of patients getting medical cannabis recommendations when 
they don’t need it motivated me to aim to educate medical practitioners and remind them 
of other screening tools that have been tested through research. As an advanced-practice 
nurse, I decided that staff education will work best to increase the knowledge among the 
health care providers involved in the screening process of patients seeking medical 
cannabis recommendation. Through years of practice, I have seen how lack of knowledge 
will not only hurt patients but the health care industry as well.  
 As a DNP-prepared practitioner, my aim was to educate colleagues of the 
existence of evidence-based and user-friendly screening tools that will address the issue 
of patients becoming too familiar with the existing tools and manipulate them. As a 
medical professional motivated to be an effective agent of change, I made sure my 
project was focused on improving not only my project skills but most importantly the 
patient outcomes. 
 Within the completion of the project, I was able to efficiently initiate the staff 
education program, successfully complete it, and I have further honed my project skills. 
Therefore, I am able to move forward with my long-term professional goals such as to 
put more effort in staff education and be more active in quality improvement ventures 
that will reinforce evidence-based practice and improved patient outcomes.   
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Summary 
As an advanced-practice nurse, I believe that status quo is no longer applicable in 
today’s health care structure and that I should move forward and aim to be more capable 
in promoting efficient policy development. In my attempt to effectively introduce change 
and ensure positive patient outcomes, I collaborated with the health care providers in the 
target organization and did a thorough literature study. These efforts resulted in efficient 
and successful initiation and completion of staff education program where the 
beneficiaries were reminded of other screening tools which have been used and tested 
through research.  
I may not have implemented the planned change but I am confident that I was 
able to make a noteworthy contribution as I was able to communicate the guidelines to 
the organization’s leaders and policymakers; and these guidelines may be used by their 
organization to address the rate of substance abuse which is one of the leading health 
problems in the United States (Bonn-Miller et al., 2013). 
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Appendix B: Diagnostic and Statistical Manual of Mental Disorders 5  
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Appendix C: Diagnostic and Statistical Manual of Mental Disorders 5  
Level 2- Anxiety – Adult 
Instructions to Clinicians 
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